RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Medical Developments International Stock

Medical Developments International P/S 2024

Medical Developments International P/S

1.1

Ticker

MVP.AX

ISIN

AU000000MVP2

WKN

A0BLXB

As of Nov 17, 2024, Medical Developments International's P/S ratio stood at 1.1, a -50.23% change from the 2.21 P/S ratio recorded in the previous year.

The Medical Developments International P/S history

Medical Developments International Aktienanalyse

What does Medical Developments International do?

Medical Developments International Ltd is an Australian company specializing in the development and production of medical devices and products. The company was founded in 1971 by renowned researcher and entrepreneur Mark Sullivan and has since received numerous awards and accolades. The company's business model is based on the manufacture of emergency medical devices and products of the highest quality and effectiveness. It has three main business segments: Pharmaceuticals, Medical devices, and Animal health. Medical Developments International ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Medical Developments International's P/S Ratio

Medical Developments International's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Medical Developments International's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Medical Developments International's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Medical Developments International’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Medical Developments International stock

What is the price-to-earnings ratio of Medical Developments International?

The price-earnings ratio of Medical Developments International is currently 1.1.

How has the price-earnings ratio of Medical Developments International changed compared to last year?

The price-to-earnings ratio of Medical Developments International has increased by -50.23% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Medical Developments International high compared to other companies?

Yes, the price-to-earnings ratio of Medical Developments International is high compared to other companies.

How does an increase in the price-earnings ratio of Medical Developments International affect the company?

An increase in the price-earnings ratio of Medical Developments International would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Medical Developments International affect the company?

A decrease in the price-earnings ratio of Medical Developments International would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Medical Developments International?

Some factors that influence the price-earnings ratio of Medical Developments International are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Medical Developments International pay?

Over the past 12 months, Medical Developments International paid a dividend of 0.03 AUD . This corresponds to a dividend yield of about 6.34 %. For the coming 12 months, Medical Developments International is expected to pay a dividend of -0.41 AUD.

What is the dividend yield of Medical Developments International?

The current dividend yield of Medical Developments International is 6.34 %.

When does Medical Developments International pay dividends?

Medical Developments International pays a quarterly dividend. This is distributed in the months of September, April, October, April.

How secure is the dividend of Medical Developments International?

Medical Developments International paid dividends every year for the past 1 years.

What is the dividend of Medical Developments International?

For the upcoming 12 months, dividends amounting to -0.41 AUD are expected. This corresponds to a dividend yield of -93.71 %.

In which sector is Medical Developments International located?

Medical Developments International is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medical Developments International kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medical Developments International from 4/17/2020 amounting to 0.028 AUD, you needed to have the stock in your portfolio before the ex-date on 3/5/2020.

When did Medical Developments International pay the last dividend?

The last dividend was paid out on 4/17/2020.

What was the dividend of Medical Developments International in the year 2023?

In the year 2023, Medical Developments International distributed 0 AUD as dividends.

In which currency does Medical Developments International pay out the dividend?

The dividends of Medical Developments International are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Medical Developments International

Our stock analysis for Medical Developments International Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medical Developments International Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.